Dr. Alyssa S. Daniel, MD
Dermatology (Dermatology Physician)
- Medicare participating
At a glance
- Years since graduation
- 16
- In the NPI registry since
- 2010
- Medicare patients seen, 2024
- 195
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2010Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
NC license 2014-00838 -
Internal Medicine Physician
NC license 165244
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Metrolina Dermatology and Skin Surgery Specialists PLLC (38 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 195
- Services billed
- 837
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 97 | 18 |
| Established patient office or other outpatient visit, 30-39 minutes | 82 | 50 |
| Established patient office or other outpatient visit, 20-29 minutes | 56 | 40 |
| Biopsy of related skin growth, first growth | 50 | 38 |
| New patient office or other outpatient visit, 45-59 minutes | 44 | 44 |
| Destruction of precancer skin growth, 1 growth | 33 | 22 |
| Destruction of skin growth, 1-14 growths | 27 | 26 |
| Biopsy of related skin growth, each additional growth | 25 | 14 |
| New patient office or other outpatient visit, 30-44 minutes | 25 | 25 |
| Established patient office or other outpatient visit, 10-19 minutes | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 10 companies reported 15 payments worth $562 in total to this clinician.
| Lilly USA, LLC | $125 |
|---|---|
| Janssen Biotech, Inc. | $120 |
| Sun Pharmaceutical Industries Inc. | $94.67 |
| AbbVie Inc. | $76.73 |
| Novartis Pharmaceuticals Corporation | $42.07 |
| Pfizer Inc. | $28.40 |
| Genzyme Corporation | $23.08 |
| Galderma Laboratories, L.P. | $22.76 |
| Food and Beverage | $462 |
|---|---|
| Education | $99.99 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. Aug 9, 2025 | Education TREMFYA · Immunology · in-kind | $99.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.